Delivery Order SPE2DB24D1021-SPE2DB25FEWTP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,595.70 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors, with completion scheduled for May 21, 2025. The contract employs firm fixed price pricing with no set-aside designation, reflecting competitive procurement. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and operates as a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at approximately $42,601.58 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion on June 20, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,709.46 for Dupixent 300 mg/2 ml pen auto-injectors on a firm fixed price basis. The contract was competitively awarded without set-aside provisions and is scheduled for completion by June 5, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and...
- The Defense Logistics Agency awarded a $73,368.18 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors, with an ultimate completion date of September 10, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $79,739.95 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors (2 ml units) on July 15, 2025, with completion expected by July 16, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $15,733.89 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors, with performance in Conshohocken, Pennsylvania and completion targeted for September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed on September 10, 2025. The contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $9,133.25 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dupixent 300 mg/2 ml pen injections. This is a firm fixed price delivery order with an ultimate completion date of July 29, 2025, representing a short-duration pharmaceutical supply contract. The award carries no set-aside designation, indicating it was competitively awarded through open procurement processes. AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $6,117.04. This non-set-aside contract is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The work will be...
- The Defense Logistics Agency awarded a $16,998.05 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on July 14, 2025, with completion scheduled for July 15, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery is scheduled to occur at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $22,972.76 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors on August 14, 2025, with completion expected by August 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEWTPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,374.91 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors. The contract is competitively awarded with no set-aside designation and operates under a firm fixed-price structure with a delivery completion date of May 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion contract vehicle running through December 2026 that enables the contractor to supply pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly within the Defense Health Agency and military healthcare systems. The company has demonstrated extensive capability in delivering diverse pharmaceutical products ranging from specialty medications to vaccines and medical devices through multiple competitively awarded contracts with DLA. This Dupixent supply order represents a continuation of AmerisourceBergen's role as a primary pharmaceutical supplier within the federal medical supply chain, supporting military and veteran healthcare needs with brand-name medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 5/14/25 |